David A Silbersweig, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosciences | 7 | 2023 | 348 | 1.940 |
Why?
|
| Limbic System | 8 | 2011 | 426 | 1.820 |
Why?
|
| Emotions | 20 | 2022 | 2661 | 1.530 |
Why?
|
| Frontal Lobe | 8 | 2017 | 1406 | 1.460 |
Why?
|
| Brain Mapping | 41 | 2015 | 6669 | 1.150 |
Why?
|
| Somatoform Disorders | 2 | 2022 | 423 | 1.070 |
Why?
|
| Hallucinations | 9 | 2022 | 360 | 1.050 |
Why?
|
| Mental Disorders | 10 | 2023 | 6600 | 1.040 |
Why?
|
| Brain | 44 | 2023 | 26385 | 1.030 |
Why?
|
| Gyrus Cinguli | 8 | 2013 | 1091 | 1.020 |
Why?
|
| Neuropsychiatry | 2 | 2015 | 55 | 0.990 |
Why?
|
| Psychiatry | 5 | 2021 | 1695 | 0.980 |
Why?
|
| Tomography, Emission-Computed | 26 | 2001 | 1144 | 0.960 |
Why?
|
| Nerve Net | 11 | 2021 | 2174 | 0.910 |
Why?
|
| Amygdala | 10 | 2019 | 1315 | 0.880 |
Why?
|
| Prefrontal Cortex | 13 | 2021 | 2147 | 0.860 |
Why?
|
| Needs Assessment | 3 | 2016 | 1147 | 0.780 |
Why?
|
| Ultrasonic Therapy | 1 | 2023 | 235 | 0.770 |
Why?
|
| Psychotherapy | 5 | 2023 | 1643 | 0.770 |
Why?
|
| Conversion Disorder | 2 | 2014 | 205 | 0.720 |
Why?
|
| Mental Processes | 4 | 2006 | 249 | 0.710 |
Why?
|
| Physicians, Primary Care | 3 | 2016 | 591 | 0.690 |
Why?
|
| Migraine Disorders | 3 | 2016 | 1620 | 0.680 |
Why?
|
| Awareness | 2 | 2014 | 640 | 0.670 |
Why?
|
| Central Nervous System Diseases | 1 | 2023 | 518 | 0.650 |
Why?
|
| Magnetic Resonance Imaging | 52 | 2022 | 35421 | 0.650 |
Why?
|
| Encephalitis | 3 | 2022 | 423 | 0.560 |
Why?
|
| Borderline Personality Disorder | 6 | 2015 | 736 | 0.550 |
Why?
|
| Fear | 7 | 2015 | 1440 | 0.540 |
Why?
|
| Auditory Perception | 7 | 2005 | 569 | 0.530 |
Why?
|
| Schizophrenia | 13 | 2022 | 6882 | 0.520 |
Why?
|
| Psychomotor Performance | 8 | 2015 | 1901 | 0.460 |
Why?
|
| Semantics | 5 | 2021 | 584 | 0.450 |
Why?
|
| Dominance, Cerebral | 8 | 2012 | 635 | 0.450 |
Why?
|
| Models, Psychological | 1 | 2017 | 811 | 0.440 |
Why?
|
| Psychophysiologic Disorders | 1 | 2014 | 228 | 0.440 |
Why?
|
| Epilepsy | 3 | 2014 | 3310 | 0.430 |
Why?
|
| Program Development | 1 | 2019 | 1316 | 0.430 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 417 | 0.410 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 47 | 0.410 |
Why?
|
| Sex Characteristics | 3 | 2007 | 2585 | 0.400 |
Why?
|
| Panic Disorder | 4 | 2010 | 616 | 0.390 |
Why?
|
| Memory | 3 | 2015 | 2174 | 0.390 |
Why?
|
| Somatosensory Cortex | 3 | 2014 | 528 | 0.390 |
Why?
|
| Movement Disorders | 1 | 2014 | 445 | 0.390 |
Why?
|
| Models, Neurological | 2 | 2017 | 1774 | 0.390 |
Why?
|
| Verbal Behavior | 4 | 2007 | 339 | 0.390 |
Why?
|
| Hydrocortisone | 2 | 2009 | 1826 | 0.380 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 3923 | 0.380 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 840 | 0.370 |
Why?
|
| Hippocampus | 6 | 2015 | 3675 | 0.370 |
Why?
|
| Nervous System Diseases | 2 | 2017 | 1622 | 0.360 |
Why?
|
| Parietal Lobe | 2 | 2013 | 838 | 0.340 |
Why?
|
| Isoquinolines | 1 | 2011 | 367 | 0.340 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2011 | 231 | 0.340 |
Why?
|
| Positron-Emission Tomography | 8 | 2022 | 6234 | 0.330 |
Why?
|
| Propofol | 1 | 2015 | 629 | 0.330 |
Why?
|
| Space Perception | 3 | 2007 | 475 | 0.330 |
Why?
|
| Rest | 2 | 2013 | 901 | 0.330 |
Why?
|
| Combat Disorders | 1 | 2010 | 302 | 0.320 |
Why?
|
| Humans | 119 | 2023 | 744343 | 0.320 |
Why?
|
| Meningioma | 1 | 2017 | 1209 | 0.320 |
Why?
|
| Malformations of Cortical Development | 1 | 2011 | 200 | 0.320 |
Why?
|
| Neural Pathways | 5 | 2012 | 2972 | 0.310 |
Why?
|
| Premenstrual Syndrome | 2 | 2008 | 109 | 0.310 |
Why?
|
| Delirium | 1 | 2019 | 1609 | 0.310 |
Why?
|
| Image Processing, Computer-Assisted | 19 | 2016 | 8949 | 0.300 |
Why?
|
| Brain Diseases | 3 | 2023 | 1563 | 0.300 |
Why?
|
| Functional Laterality | 8 | 2011 | 2290 | 0.300 |
Why?
|
| Depressive Disorder, Major | 3 | 2019 | 4644 | 0.290 |
Why?
|
| Basal Ganglia | 2 | 2007 | 546 | 0.290 |
Why?
|
| Sound | 3 | 2005 | 260 | 0.290 |
Why?
|
| Oxygen | 7 | 2015 | 4189 | 0.290 |
Why?
|
| Health Policy | 1 | 2019 | 2661 | 0.280 |
Why?
|
| Parahippocampal Gyrus | 3 | 2015 | 116 | 0.280 |
Why?
|
| Psychoanalytic Theory | 2 | 2004 | 143 | 0.270 |
Why?
|
| Public Health | 1 | 2019 | 2603 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 9 | 2005 | 2731 | 0.260 |
Why?
|
| Tourette Syndrome | 2 | 2006 | 379 | 0.260 |
Why?
|
| Neuroanatomy | 1 | 2005 | 66 | 0.260 |
Why?
|
| Brain Stem | 2 | 2010 | 846 | 0.250 |
Why?
|
| Motivation | 1 | 2015 | 1971 | 0.250 |
Why?
|
| Psychotic Disorders | 3 | 2015 | 3046 | 0.250 |
Why?
|
| Saliva | 1 | 2009 | 809 | 0.250 |
Why?
|
| Mesencephalon | 3 | 2022 | 329 | 0.250 |
Why?
|
| Neuropsychological Tests | 11 | 2021 | 6993 | 0.240 |
Why?
|
| Rotation | 1 | 2006 | 523 | 0.240 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 8037 | 0.240 |
Why?
|
| Depressive Disorder | 5 | 2006 | 3748 | 0.240 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2020 | 4266 | 0.240 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2576 | 0.240 |
Why?
|
| Psychoanalysis | 1 | 2004 | 87 | 0.240 |
Why?
|
| Auditory Cortex | 3 | 2002 | 346 | 0.230 |
Why?
|
| Cognition | 6 | 2021 | 6770 | 0.220 |
Why?
|
| Substantia Nigra | 2 | 2020 | 353 | 0.220 |
Why?
|
| Cerebral Cortex | 10 | 2022 | 5708 | 0.220 |
Why?
|
| Adult | 57 | 2022 | 214055 | 0.220 |
Why?
|
| Reaction Time | 5 | 2015 | 2097 | 0.220 |
Why?
|
| Motor Cortex | 5 | 2007 | 986 | 0.220 |
Why?
|
| Neurology | 2 | 2023 | 763 | 0.220 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5137 | 0.220 |
Why?
|
| Ethicists | 1 | 2022 | 37 | 0.220 |
Why?
|
| Photic Stimulation | 7 | 2022 | 2025 | 0.210 |
Why?
|
| Magnetoencephalography | 3 | 2001 | 623 | 0.210 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 32 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
| Female | 60 | 2022 | 380194 | 0.200 |
Why?
|
| Movement | 3 | 2007 | 1471 | 0.200 |
Why?
|
| Visual Perception | 2 | 2015 | 1420 | 0.200 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 2838 | 0.200 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2022 | 99 | 0.190 |
Why?
|
| Oxygen Radioisotopes | 6 | 2001 | 76 | 0.190 |
Why?
|
| Male | 63 | 2023 | 350118 | 0.190 |
Why?
|
| Psychoanalytic Therapy | 1 | 2003 | 230 | 0.190 |
Why?
|
| Putamen | 1 | 2022 | 291 | 0.190 |
Why?
|
| Psychophysiology | 2 | 2015 | 135 | 0.180 |
Why?
|
| Septal Nuclei | 1 | 2020 | 85 | 0.180 |
Why?
|
| Diagnostic Imaging | 2 | 2006 | 3507 | 0.180 |
Why?
|
| Volition | 2 | 2000 | 63 | 0.180 |
Why?
|
| Socialization | 1 | 2019 | 87 | 0.180 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 229 | 0.170 |
Why?
|
| Artifacts | 5 | 2005 | 1904 | 0.170 |
Why?
|
| Affect | 2 | 2006 | 1476 | 0.170 |
Why?
|
| Mental Recall | 3 | 2020 | 1205 | 0.170 |
Why?
|
| Caudate Nucleus | 1 | 2000 | 393 | 0.170 |
Why?
|
| Comorbidity | 4 | 2019 | 10388 | 0.170 |
Why?
|
| Bioethical Issues | 1 | 2020 | 124 | 0.170 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 12959 | 0.160 |
Why?
|
| Interprofessional Relations | 1 | 2004 | 1011 | 0.160 |
Why?
|
| Facial Expression | 1 | 2022 | 508 | 0.160 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4245 | 0.160 |
Why?
|
| Verbal Learning | 3 | 2008 | 467 | 0.160 |
Why?
|
| Cognition Disorders | 4 | 2011 | 4043 | 0.160 |
Why?
|
| Neural Inhibition | 3 | 2007 | 602 | 0.150 |
Why?
|
| Middle Aged | 34 | 2022 | 213383 | 0.150 |
Why?
|
| Social Isolation | 1 | 2020 | 365 | 0.150 |
Why?
|
| Language | 3 | 2022 | 1471 | 0.150 |
Why?
|
| Deglutition Disorders | 1 | 2023 | 605 | 0.150 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 5 | 2011 | 1107 | 0.150 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 442 | 0.140 |
Why?
|
| Consciousness | 2 | 2000 | 572 | 0.140 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 236 | 0.140 |
Why?
|
| Anxiety | 2 | 2022 | 4297 | 0.140 |
Why?
|
| Acoustic Stimulation | 5 | 2005 | 1216 | 0.130 |
Why?
|
| Endophenotypes | 1 | 2017 | 250 | 0.130 |
Why?
|
| Receptors, GABA-A | 2 | 2015 | 627 | 0.130 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 3079 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 975 | 0.120 |
Why?
|
| Reward | 2 | 2015 | 941 | 0.120 |
Why?
|
| Electroencephalography | 5 | 2022 | 6150 | 0.120 |
Why?
|
| Arousal | 4 | 2007 | 1165 | 0.120 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 518 | 0.120 |
Why?
|
| Optic Nerve | 1 | 2017 | 554 | 0.120 |
Why?
|
| Social Stigma | 1 | 2020 | 701 | 0.120 |
Why?
|
| Psychology | 1 | 2015 | 356 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 1223 | 0.110 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 857 | 0.110 |
Why?
|
| Menstrual Cycle | 2 | 2008 | 551 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 617 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1531 | 0.110 |
Why?
|
| Delusions | 1 | 2015 | 300 | 0.110 |
Why?
|
| Social Behavior | 1 | 2019 | 1127 | 0.110 |
Why?
|
| Bipolar Disorder | 2 | 2000 | 5027 | 0.110 |
Why?
|
| Epilepsies, Partial | 1 | 2016 | 436 | 0.100 |
Why?
|
| Reading | 3 | 2022 | 558 | 0.100 |
Why?
|
| Microglia | 1 | 2020 | 1266 | 0.100 |
Why?
|
| Neocortex | 1 | 2015 | 400 | 0.100 |
Why?
|
| Imagination | 2 | 2007 | 221 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1881 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2915 | 0.100 |
Why?
|
| Auditory Perceptual Disorders | 2 | 2005 | 36 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2017 | 1534 | 0.100 |
Why?
|
| Pilot Projects | 4 | 2019 | 8324 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 2690 | 0.100 |
Why?
|
| Vocabulary | 1 | 2011 | 169 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2020 | 2050 | 0.090 |
Why?
|
| Luteal Phase | 2 | 2007 | 147 | 0.090 |
Why?
|
| Follicular Phase | 2 | 2007 | 153 | 0.090 |
Why?
|
| Parkinson Disease | 2 | 2022 | 2775 | 0.090 |
Why?
|
| Galvanic Skin Response | 2 | 2012 | 349 | 0.090 |
Why?
|
| Pattern Recognition, Visual | 2 | 2006 | 824 | 0.090 |
Why?
|
| Psychotherapy, Brief | 1 | 2010 | 114 | 0.090 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 659 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2017 | 2740 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 4740 | 0.080 |
Why?
|
| Neoplasms | 1 | 2017 | 21683 | 0.080 |
Why?
|
| Neuronal Plasticity | 2 | 2014 | 1422 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.080 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2009 | 113 | 0.080 |
Why?
|
| Conditioning, Classical | 1 | 2010 | 366 | 0.080 |
Why?
|
| Corpus Striatum | 2 | 2007 | 1221 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2011 | 6038 | 0.070 |
Why?
|
| Behavior | 2 | 2009 | 561 | 0.070 |
Why?
|
| Pons | 2 | 2006 | 245 | 0.070 |
Why?
|
| Veterans | 1 | 2020 | 2519 | 0.070 |
Why?
|
| Reticular Formation | 1 | 2006 | 61 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7785 | 0.070 |
Why?
|
| Forecasting | 2 | 2006 | 2951 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3057 | 0.070 |
Why?
|
| Mental Health | 1 | 2020 | 3019 | 0.070 |
Why?
|
| Raphe Nuclei | 1 | 2006 | 104 | 0.070 |
Why?
|
| Speech Perception | 3 | 2001 | 489 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7722 | 0.070 |
Why?
|
| Syndrome | 1 | 2012 | 3251 | 0.070 |
Why?
|
| Cerebrovascular Disorders | 4 | 1997 | 1504 | 0.060 |
Why?
|
| Peroxides | 1 | 2005 | 74 | 0.060 |
Why?
|
| Attention | 6 | 2003 | 2400 | 0.060 |
Why?
|
| Locus Coeruleus | 1 | 2006 | 176 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2006 | 142 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15540 | 0.060 |
Why?
|
| Memory Disorders | 2 | 2023 | 1184 | 0.060 |
Why?
|
| Orientation | 1 | 2006 | 327 | 0.060 |
Why?
|
| Personality Inventory | 1 | 2007 | 1030 | 0.060 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 178 | 0.060 |
Why?
|
| Adolescent | 9 | 2022 | 85781 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2006 | 569 | 0.060 |
Why?
|
| Nucleus Accumbens | 1 | 2006 | 366 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2015 | 1643 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2005 | 302 | 0.060 |
Why?
|
| Speech | 3 | 2000 | 540 | 0.060 |
Why?
|
| Dreams | 1 | 2004 | 147 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2005 | 454 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2005 | 363 | 0.060 |
Why?
|
| Urea | 1 | 2005 | 450 | 0.060 |
Why?
|
| Models, Biological | 1 | 2019 | 9583 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 20822 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
| Young Adult | 8 | 2022 | 56430 | 0.050 |
Why?
|
| Regional Blood Flow | 4 | 1999 | 1525 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2003 | 165 | 0.050 |
Why?
|
| Motion Perception | 1 | 2006 | 408 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 780 | 0.050 |
Why?
|
| GABA Modulators | 2 | 2000 | 107 | 0.050 |
Why?
|
| Image Enhancement | 2 | 2003 | 2921 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2007 | 803 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3870 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2016 | 9146 | 0.050 |
Why?
|
| Military Personnel | 1 | 2010 | 1133 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2002 | 4199 | 0.050 |
Why?
|
| Spin Labels | 4 | 2005 | 332 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2645 | 0.050 |
Why?
|
| Visual Pathways | 1 | 2005 | 565 | 0.050 |
Why?
|
| Amnesia | 1 | 2023 | 248 | 0.050 |
Why?
|
| Water | 2 | 1999 | 1395 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5751 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2003 | 475 | 0.050 |
Why?
|
| Hearing Loss, Central | 1 | 2000 | 16 | 0.050 |
Why?
|
| Geriatric Assessment | 4 | 2001 | 1372 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2005 | 1767 | 0.050 |
Why?
|
| Flumazenil | 1 | 2000 | 84 | 0.050 |
Why?
|
| Hostility | 1 | 2021 | 189 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2005 | 1959 | 0.040 |
Why?
|
| Tics | 1 | 2000 | 70 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.040 |
Why?
|
| Social Environment | 1 | 2005 | 1023 | 0.040 |
Why?
|
| Patient Care Team | 2 | 2015 | 2531 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2000 | 379 | 0.040 |
Why?
|
| Linguistics | 1 | 1999 | 97 | 0.040 |
Why?
|
| Acetanilides | 1 | 2020 | 168 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4558 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 642 | 0.040 |
Why?
|
| Environment | 1 | 2005 | 1124 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2025 | 0.040 |
Why?
|
| Auditory Pathways | 1 | 2000 | 233 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2373 | 0.040 |
Why?
|
| Reference Values | 3 | 2001 | 4982 | 0.040 |
Why?
|
| Schizophrenic Psychology | 2 | 2015 | 1678 | 0.040 |
Why?
|
| Temporal Lobe | 2 | 2022 | 1670 | 0.040 |
Why?
|
| Music | 1 | 2001 | 263 | 0.040 |
Why?
|
| Primates | 1 | 2000 | 545 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 553 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2624 | 0.040 |
Why?
|
| Midazolam | 1 | 1998 | 270 | 0.040 |
Why?
|
| Atrophy | 1 | 2021 | 1583 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2016 | 21746 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6365 | 0.030 |
Why?
|
| Aged | 12 | 2023 | 163280 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 703 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 1032 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 1997 | 250 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1534 | 0.030 |
Why?
|
| Learning | 1 | 2005 | 1713 | 0.030 |
Why?
|
| Agnosia | 1 | 1995 | 66 | 0.030 |
Why?
|
| Language Tests | 1 | 2015 | 200 | 0.030 |
Why?
|
| Periaqueductal Gray | 1 | 2015 | 107 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2006 | 19905 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 1996 | 253 | 0.030 |
Why?
|
| Event-Related Potentials, P300 | 1 | 1995 | 150 | 0.030 |
Why?
|
| Radioisotopes | 1 | 1996 | 499 | 0.030 |
Why?
|
| Deafness | 1 | 1998 | 458 | 0.030 |
Why?
|
| Algorithms | 4 | 2003 | 13881 | 0.030 |
Why?
|
| Aphasia | 1 | 2015 | 179 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2000 | 1056 | 0.030 |
Why?
|
| Time Factors | 5 | 2016 | 40075 | 0.030 |
Why?
|
| Family Therapy | 1 | 2015 | 207 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 2035 | 0.030 |
Why?
|
| Thinking | 1 | 1996 | 319 | 0.030 |
Why?
|
| Electricity | 1 | 1993 | 182 | 0.030 |
Why?
|
| United States | 1 | 2020 | 69872 | 0.030 |
Why?
|
| Skin | 1 | 2005 | 4364 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2003 | 2737 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3479 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2015 | 406 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6386 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3086 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3587 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 72290 | 0.020 |
Why?
|
| Motor Neurons | 1 | 1995 | 844 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2003 | 3327 | 0.020 |
Why?
|
| Curriculum | 1 | 2003 | 3605 | 0.020 |
Why?
|
| Animals | 6 | 2019 | 168757 | 0.020 |
Why?
|
| Carnitine | 1 | 1990 | 246 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 1997 | 1161 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2015 | 63114 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 941 | 0.020 |
Why?
|
| Child | 3 | 2020 | 77709 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 53288 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.020 |
Why?
|
| Mathematics | 1 | 2006 | 728 | 0.020 |
Why?
|
| Fingers | 2 | 2000 | 513 | 0.020 |
Why?
|
| Age Factors | 1 | 2001 | 18370 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2708 | 0.010 |
Why?
|
| Motor Activity | 3 | 2002 | 2714 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2003 | 14722 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2003 | 171 | 0.010 |
Why?
|
| Boston | 1 | 2015 | 9313 | 0.010 |
Why?
|
| Hemorheology | 1 | 2002 | 145 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2015 | 3209 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
| Tape Recording | 1 | 2000 | 76 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18029 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5952 | 0.010 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2000 | 29 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39050 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 845 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2006 | 1431 | 0.010 |
Why?
|
| Audiometry | 1 | 2000 | 241 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2003 | 6196 | 0.010 |
Why?
|
| Inpatients | 1 | 2010 | 2518 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2000 | 525 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 1423 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 2000 | 536 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5319 | 0.010 |
Why?
|
| Guilt | 1 | 1997 | 95 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 1997 | 152 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1996 | 337 | 0.010 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1995 | 204 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2003 | 2480 | 0.010 |
Why?
|
| Psychomotor Agitation | 1 | 1997 | 293 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1997 | 354 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77449 | 0.010 |
Why?
|
| Violence | 1 | 1999 | 909 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81183 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 40561 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10397 | 0.010 |
Why?
|
| Hearing | 1 | 1995 | 482 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2327 | 0.010 |
Why?
|
| Arm | 1 | 1995 | 589 | 0.010 |
Why?
|
| Electromyography | 1 | 1995 | 1379 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1990 | 195 | 0.010 |
Why?
|
| Age of Onset | 1 | 1997 | 3271 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2002 | 3589 | 0.010 |
Why?
|
| Leg | 1 | 1995 | 1116 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 1997 | 1827 | 0.010 |
Why?
|
| Thalamus | 1 | 1995 | 1023 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1996 | 2016 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1990 | 2557 | 0.000 |
Why?
|
| Arteries | 1 | 1990 | 1119 | 0.000 |
Why?
|
| Neurons | 1 | 2003 | 9338 | 0.000 |
Why?
|
| Disease Progression | 1 | 1997 | 13284 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2003 | 41006 | 0.000 |
Why?
|
| Stroke | 1 | 2000 | 9981 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1990 | 8554 | 0.000 |
Why?
|
| Rats | 1 | 1990 | 24260 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 57776 | 0.000 |
Why?
|